Alzheimer’s Disease Pilot Clinical Trials (R01)

The objective of the Alzheimer’s Disease Pilot Clinical Trials initiative is to improve the quality of clinical research designed to evaluate interventions for the prevention and treatment of Alzheimer’s disease (AD), mild cognitive impairment (MCI), and age-associated cognitive decline by stimulating applications for pilot clinical trials to test drug and/or behavioral interventions aimed at delaying the onset of or preventing AD, MCI, and age-associated cognitive decline; slowing, halting, or, if possible, reversing the progressive decline in cognitive function; and modifying the cognitive and behavioral symptoms in AD and MCI.

Read more about this funding opportunity